Theodore S Ingrassia Iii, MD | |
535 Roxbury Rd, Suite B600, Rockford, IL 61107-5076 | |
(815) 397-7212 | |
(815) 397-2539 |
Full Name | Theodore S Ingrassia Iii |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 42 Years |
Location | 535 Roxbury Rd, Rockford, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437263662 | NPI | - | NPPES |
101 00686 | Other | IL | BLUE CROSS BLUE SHIELD |
036 083892 | Medicaid | IL | |
110060997 | Other | IL | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 036 083892 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Osf Saint Anthony Medical Center | Rockford, IL | Hospital |
Osf Little Company Of Mary Medical Center | Evergreen park, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.
In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias.
While many businesses in this southwestern Montana "ghost town" reel in tourists with its mining and Wild West vigilante past, one businessman arrived offering a modern product: covid-19 vaccines.
The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) today announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs).
› Verified 6 days ago
Entity Name | Osf Multi-specialty Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.
In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias.
While many businesses in this southwestern Montana "ghost town" reel in tourists with its mining and Wild West vigilante past, one businessman arrived offering a modern product: covid-19 vaccines.
The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) today announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Theodore S Ingrassia Iii, MD 535 Roxbury Rd, Suite B600, Rockford, IL 61107-5076 Ph: (815) 397-7212 | Theodore S Ingrassia Iii, MD 535 Roxbury Rd, Suite B600, Rockford, IL 61107-5076 Ph: (815) 397-7212 |
News Archive
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.
In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias.
While many businesses in this southwestern Montana "ghost town" reel in tourists with its mining and Wild West vigilante past, one businessman arrived offering a modern product: covid-19 vaccines.
The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) today announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs).
› Verified 6 days ago
Dr. Adekola Abioudun Ashaye, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 W State St, Rockford, IL 61102 Phone: 815-490-1600 Fax: 815-490-1881 | |
Prasad K. Kilaru, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2350 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-2000 | |
David R. Mitchell, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5970 Churchview Dr, Rockford, IL 61107 Phone: 815-971-2000 | |
Dr. Amrutha Mary George, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1253 N Alpine Rd, Rockford, IL 61107 Phone: 779-696-9201 | |
Rajyalaxmi Mullapudi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-226-2000 | |
Geoffrey Tsaras, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1340 Charles St Ste 404, Rockford, IL 61104 Phone: 779-696-1890 Fax: 779-696-2410 | |
Stephanie Birmingham, APN Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-5000 |